Antonio Federico

Antonio Federico

Auto-generated profile, based on publicly available information

Antonio Federico

University of Siena

Research Focus & Metrics

Academic Career Length

53Years (1974-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2002 in NeuroImage
Verified
Journal Article
Closed access
SSStephen M. Smith
Stephen M. Smith
YZYongyue Zhanga
Yongyue Zhanga
MJMark Jenkinsona
Mark Jenkinsona
JCJacqueline Chenab
Jacqueline Chenab
PMP.M. Matthews
P.M. Matthews
NSNicola De Stefano
Nicola De Stefano

1 November 2012 in Journal of the Neurological Sciences
Verified
Journal Article
Closed access
AFAntonio Federico
Antonio Federico
ECElena Cardaioli
Elena Cardaioli
PPPaola Da Pozzo
Paola Da Pozzo
PFPatrizia Formichi
Patrizia Formichi
GGGian Nicola Gallus
Gian Nicola Gallus
ERElena Radi
Elena Radi

2 September 2014 in Journal of Alzheimer’s Disease
Verified
Journal Article
Closed access
PDF file
ERElena Radi
Elena Radi
PFPatrizia Formichi
Patrizia Formichi
CBCarla Battisti
Carla Battisti
AFAntonio Federico
Antonio Federico
Neurodegenerative disorders affect almost 30 million individuals leading to disability and death. These disorders are characterized by pathological changes in disease-specific areas of the brain and degeneration of distinct neuron subsets. Despite th

8 April 2003 in Neurology
Verified
Journal Article
Closed access
PDF file
NSN. De Stefano
N. De Stefano
PMP. M. Matthews
P. M. Matthews
Massimo FilippiMassimo Filippi
Massimo Filippi
FAFederica Agosta
Federica Agosta
MLM. De Luca
M. De Luca
SSS. M. Smith
S. M. Smith
Objective: To assess cortical gray matter (GM) changes in MS and establish their relevance to clinical disability and to inflammatory changes of white matter (WM) in patients with the relapsing–remitting (RR) and primary progressive (PP) forms of the disease. Methods: Conventional MRI examinations were obtained in patients with definite MS who had either the RR or the PP form of the disease. An automated analysis tool was used with conventional T1-weighted MR images to obtain total and cortical brain volumes normalized for head size. Total brain lesion load was estimated on conventional proton density and T2-weighted MR images. The relationship between volumetric MR measures and scores of clinical disability was assessed. Results: Normalized cortical volumes (NCV) were lower for both RR and PP MS patients than for normal control subjects (p < 0.001) but were similar between the two patient groups (p > 0.5). NCV decreases in both patients groups were detected even in those patients with short disease duration (<5 years; p < 0.001 in RR MS and p < 0.05 in PP MS) and minimal brain lesion volume (<5 mL; p < 0.0001 in RR MS and p < 0.005 in PP MS). Measures of NCV in individual patients were negatively correlated with T2-weighted lesion volume (r = −0.47, p < 0.001) and disease duration (r = −0.25, p < 0.05) only in the patients with RR MS. NCV correlated with Expanded Disability Status Scale scores across all of the patients, but the strength of the correlation was stronger (p < 0.05) for PP (r = −0.64, p < 0.0001) than for RR (r = −0.27, p = 0.04) MS patients. Conclusions: These data confirm substantial neocortical volume loss in MS patients and suggest that neocortical GM pathology may occur early in the course of the disease in both RR and PP MS patients and contribute significantly to neurologic impairment. Although a proportion of this neocortical pathology may be secondary to WM inflammation, the extent of the changes suggests that, especially in patients with PP MS, an independent neurodegenerative process also is active.

1 March 2012 in The American Journal of Human Genetics
Verified
Journal Article
Closed access
MQMarialuisa Quadri
Marialuisa Quadri
AFAntonio Federico
Antonio Federico
TZTianna Zhao
Tianna Zhao
GBGuido J. Breedveld
Guido J. Breedveld
CBCarla Battisti
Carla Battisti
Vincenzo BonifatiVincenzo Bonifati
Vincenzo Bonifati

13 July 2004 in Neurology
Verified
Journal Article
Closed access
PDF file
MAM. P. Amato
M. P. Amato
MBM. L. Bartolozzi
M. L. Bartolozzi
VZV. Zipoli
V. Zipoli
EPE. Portaccio
E. Portaccio
MMM. Mortilla
M. Mortilla
NSN. De Stefano
N. De Stefano
Objective: To assess neocortical changes and their relevance to cognitive impairment in early relapsing–remitting (RR) multiple sclerosis (MS). Methods: Conventional MR was acquired in 41 patients with RR MS and 16 demographically matched normal control subjects (NCs). An automated analysis tool was used with conventional T1-weighted MRI to obtain measures of cortical brain volumes normalized for head size. Neuropsychological performance of MS patients was assessed using the Rao Brief Repeatable Battery. Relationship between volumetric MR measures and neuropsychological scores was assessed. Results: Neuropsychological assessment allowed for the identification of 18 cognitively preserved (MS-cp) and 23 cognitively impaired (MS-ci) MS patients. The whole MS sample showed lower values of normalized cortical volumes (NCVs) than did the NC group (p = 0.01). Upon grouping of MS patients according to cognitive performance, NCV values were lower (p = 0.02) in MS-ci patients than in both MS-cp patients and NCs. Moreover, there were positive correlations between NCV values and measures of verbal memory (r = 0.51, p = 0.02), verbal fluency (r = 0.51, p = 0.01), and attention/concentration (r = 0.65, p < 0.001) in MS-ci patients. Furthermore, NCV values were decreased in patients who scored lower on a greater number of tests (r = −0.58, p < 0.01) in the MS-ci group. None of the neuropsychological measures correlated to NCV values in the MS-cp patient group. Conclusions: Cortical atrophy was found only in cognitively impaired patients and was significantly correlated with a poorer performance on tests of verbal memory, attention/concentration, and verbal fluency. Gray matter pathology may contribute to the development of cognitive impairment in MS from the earliest stages of the disease.